JG
OKUR

Jefferies Group’s OnKure Therapeutics OKUR Stock Holding History

Jefferies Group’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,133
Closed -$62.7K – 1912
2022
Q1 		$62.7K Buy
+2,133
New +$119K ﹤0.01% 1381

Other funds holding OKUR

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jefferies Group's OKUR Position: Q2 2022 in Review

Jefferies Group sold out of OnKure Therapeutics (OKUR) in Q2 2022, closing a stake of 2,133 shares — an estimated $62.7K sold.

Jefferies Group first reported a position in OKUR in Q1 2022 and held it in 1 quarter. The position peaked at $62.7K in Q1 2022. 33 funds tracked by Wall St. Rank hold OKUR as of Q2 2022.

  • Jefferies Group reported no remaining OnKure Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Jefferies Group sold 2,133 OnKure Therapeutics shares in Q2 2022, an estimated $62.7K.
  • Jefferies Group first reported a position in OnKure Therapeutics in Q1 2022 and held it in 1 quarter.
  • Jefferies Group's OnKure Therapeutics position peaked at $62.7K in Q1 2022.
  • 33 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q2 2022.

Based on Jefferies Group's 13F filing for Q2 2022, filed 15 Aug 2022.